Today, the NHS Innovation Accelerator (NIA) announces the 12 innovators (‘Fellows’) and innovations selected to join its award-winning programme in 2021.
These innovations offer solutions to some of the healthcare’s most pressing needs and will be supported over the next three years to scale across England for the benefit of NHS patients and staff.
This year, the NIA sought evidence-based innovations that address key NHS priorities: supporting the workforce, mental health and COVID-19 response. From remote patient monitoring and diagnostics to virtual clinical training for staff, the 2021 cohort represents a range of solutions that are set to transform the health and social care system in England.
Each innovation – and its representative Fellow – were selected through a robust, multi-stage assessment process involving a college of expert clinicians, patients and commercial leads drawn from a range of organisations including NHS England and NHS Improvement, NHSX, the Academic Health Science Networks (AHSNs) and NICE.
In recognition of the new cohort, Professor Stephen Powis, Chair of the NIA and National Medical Director for NHS England and NHS Improvement, said:
“After a year like no other for the NHS, the importance of innovation has never been more critical to ensuring we remain able to care for NHS patients and staff effectively and efficiently.
The 12 innovations joining the NHS Innovation Accelerator in 2021 meet the needs of the NHS at this critical time and will be supported to scale across England for even greater patient benefit.”
OMS is delighted to have been successfully selected for the 2021 cohort. It is an exciting development for the company and we look forward to sharing further updates as they arise.
About the NHS Innovation Accelerator
The NHS Innovation Accelerator (NIA) is an award-winning NHS England initiative delivered in partnership with England’s 15 Academic Health Science Networks (AHSNs), hosted at UCLPartners.
It supports delivery of the NHS Long Term Plan priorities by accelerating uptake of high impact innovations for patient, population and NHS staff benefit, and providing practical insights on spread to inform national strategy.